image
Protagonist Therapeutics, Inc. PTGX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 41.11
0.171 %
$ 2.45 B
Market Cap
15.0
P/E
INCOME STATEMENT
60 M REVENUE
125.73%
Growth Rates
1Year 125.73%
3Years 27.97%
5Years 14.17%
7Years 0.00%
10Years 0.00%
-93.7 M OPERATING INCOME
28.71%
Growth Rates
1Year 28.71%
3Years -13.23%
5Years -17.25%
7Years -16.24%
10Years 0.00%
-79 M NET INCOME
38.02%
Growth Rates
1Year 38.02%
3Years -6.08%
5Years -15.19%
7Years -11.36%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Protagonist Therapeutics, Inc.
image
Revenue 60 M
Cost Of Revenue 3.31 M
Gross Profit 56.7 M
Operating Expenses 154 M
Operating Income -93.7 M
Other Expenses -14.7 M
Net Income -79 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 60.0 26.6 27.4 28.6 0.2 30.9 20.1 0 0 0
GROSS PROFIT
Cost Of Revenue 3.3 1.0 2.8 0 0 0 0 0.3 0.2 0
Gross Profit 56.7 25.5 24.6 28.6 0.2 30.9 20.1 (0.3) (0.2) 0
OPERATING INCOME
Operating Expenses 153.7 158.0 153.2 93.1 80.8 73.2 58.0 32.7 14.8 9.3
Selling, General and Administrative Expenses 33.5 31.7 27.2 18.6 15.7 13.7 11.8 7.0 3.0 1.9
Research and Development Expenses 120.2 126.2 126.0 74.5 65.0 59.5 46.2 25.7 11.8 7.5
Operating Income (93.7) (131.4) (125.8) (64.5) (80.5) (42.3) (37.9) (32.7) (14.8) (9.3)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0.6 0.2 20 K 8 K 0 0 0
Total Other Income 14.7 4.0 0.3 (0.3) 2.6 2.5 0.9 (4.5) 64 K (1.8)
Pre-Tax Income (79.0) (127.4) (125.6) (64.8) (77.9) (39.7) (37.0) (37.2) (14.9) (11.1)
NET INCOME
Tax Provision 0 (4.0) (2.9) 1.3 (0.7) (0.8) (0.4) 4.2 64 K 1.8
Net Income (79.0) (123.4) (122.6) (66.2) (77.2) (38.9) (37.0) (37.2) (14.9) (11.1)
EPS 1.39 2.52 2.65 1.92 2.98 1.74 2.09 5.72 2.52 1.88